Today: 8 March 2026
Browse Category

Earnings Reports 23 January 2026

SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

SLB stock price swings after earnings beat as $4 billion return plan meets Venezuela questions

SLB shares closed nearly unchanged at $49.33 Friday after beating quarterly profit forecasts and raising its dividend, but warned of weaker first-quarter results. North America revenue jumped 26%. Executives said SLB is ready to expand in Venezuela if U.S. licensing and payment terms are resolved. Trading volume was high as investors weighed the earnings beat against a cautious outlook.
Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer shares fell 1.9% to $25.62 Friday as the stock went ex-dividend, nearly matching the $0.43 payout. The drop outpaced the health-care sector, with Moderna tumbling over 7% and Merck down 1%. Policy changes under Health Secretary Robert F. Kennedy Jr. have unsettled vaccine makers. Pfizer reports quarterly results and hosts a webcast on Feb. 3.
Capital One stock sinks nearly 7% after Brex deal and Q4 numbers; what investors watch next

Capital One stock sinks nearly 7% after Brex deal and Q4 numbers; what investors watch next

Capital One shares fell 6.8% to $219.17 Friday after it announced a $5.15 billion deal to acquire fintech Brex and posted higher fourth-quarter credit-loss provisions and expenses. The deal includes $2.75 billion in cash and 10.6 million shares, pending regulatory approval. Net income for the quarter was $2.1 billion. BTIG cut its price target, citing near-term dilution.
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher Scientific shares fell nearly 2% by midday Friday, reversing earlier gains after touching a record high near $640. The drop outpaced the broader market, with peers Danaher, Agilent, and Illumina also declining. Investors are awaiting Thermo Fisher’s fourth-quarter results, set for release before the market opens on Jan. 29. The S&P 500 was steady while the health-care sector slipped.
AMD stock rises as Intel supply warning jolts chip trade; earnings next in focus

AMD stock rises as Intel supply warning jolts chip trade; earnings next in focus

AMD shares rose 1.9% to $258.50 Friday, extending an eight-session rally after Intel warned of server chip shortages and missed forecasts. Intel stock plunged 16.7% on the news. Investors are positioning ahead of AMD’s Feb. 3 earnings, betting on data-center demand. The broader chip sector fell, with the iShares Semiconductor ETF down 1.3%.
MercadoLibre stock slips today as Brazil logistics fee hike and earnings calendar grab attention

MercadoLibre stock slips today as Brazil logistics fee hike and earnings calendar grab attention

MercadoLibre shares fell about 1% to $2,131.19 by midday Friday, underperforming the broader market after new details on a planned Brazil logistics fee hike. Itau BBA estimates the March adjustment could lift Brazil’s take rate by 80 basis points and add $280 million in annual net revenue. Investors await remarks at the Jan. 27 UBS conference and the company’s Feb. 24 earnings report.
GE Vernova stock price slips after Power unit CEO exit; earnings next week in focus

GE Vernova stock price slips after Power unit CEO exit; earnings next week in focus

GE Vernova shares fell 0.1% to $660.79 by midday Friday after hitting a session low of $649.65, extending losses from earlier in the week. Mavi Zingoni stepped down as Power segment CEO on Jan. 21, with Eric Gray taking over. Investors await the company’s Jan. 28 earnings report for updates on order flow and margins. The stock closed Wednesday at $667.89, about 8.6% below its December high.
Western Digital stock slips as Morgan Stanley lifts target to $260 ahead of earnings

Western Digital stock slips as Morgan Stanley lifts target to $260 ahead of earnings

Western Digital shares fell 2.7% to $236.81 in midday trading Friday, while Seagate slipped 1.9%. Morgan Stanley raised Western Digital’s price target to $260, citing margin strength, and other banks also lifted targets. Chief Legal Officer Cynthia Tregillis sold 447 shares at $229 each on Jan. 21. Western Digital will report fiscal Q2 results after markets close Jan. 29.
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
Visa stock inches up as traders eye Jan. 29 earnings and UK fee-cap risk

Visa stock inches up as traders eye Jan. 29 earnings and UK fee-cap risk

Visa rose 0.1% to $326.63 in midday New York trading Friday, while Mastercard fell 1.3% and American Express dropped 2.3%. Investors are watching for Visa’s fiscal first-quarter results on Jan. 29. A UK court ruling has cleared the way for possible caps on cross-border card fees, but regulators have not set details or timing. Visa remains in a quiet period ahead of its earnings release.
23 January 2026
Eli Lilly stock slips as Novo’s Wegovy pill racks up 18,000+ scripts; earnings next

Eli Lilly stock slips as Novo’s Wegovy pill racks up 18,000+ scripts; earnings next

Eli Lilly shares fell 1.1% to $1,075.78 after Novo Nordisk’s new Wegovy pill logged over 18,000 U.S. prescriptions in its first full week. Investors are watching ahead of Lilly’s Feb. 4 earnings and an expected FDA decision on its own oral obesity drug by April. Several Lilly directors recently received stock units through a deferral plan.
ServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earningsServiceNowServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earnings

ServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earningsServiceNowServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earnings

ServiceNow shares rose 3.4% Friday to $132.88, rebounding after a six-day slump as investors await next week’s earnings. Cantor Fitzgerald and Jefferies cut price targets but kept positive ratings. The stock is down 16% in 2026, while the S&P 500 is up 1%. ServiceNow and OpenAI expanded their partnership to integrate new AI models into workflows.
1 84 85 86 87 88 227
Go toTop